Title | In Vitro Antimicrobial Susceptibility of Staphylococcus pseudintermedius Isolates of Human and Animal Origin. |
Publication Type | Journal Article |
Year of Publication | 2016 |
Authors | Humphries RM, Wu MT, Westblade LF, Robertson AE, Burnham C-AD, Wallace MA, Burd EM, Lawhon S, Hindler JA |
Journal | J Clin Microbiol |
Volume | 54 |
Issue | 5 |
Pagination | 1391-4 |
Date Published | 2016 05 |
ISSN | 1098-660X |
Keywords | Animals, Anti-Bacterial Agents, Humans, Microbial Sensitivity Tests, Staphylococcal Infections, Staphylococcus intermedius |
Abstract | MIC results for 115 Staphylococcus intermedius group isolates are presented. Of these, 33% were methicillin resistant, among which 51.4% were susceptible to doxycycline, 29.7% to clindamycin, and 21.6% to trimethoprim-sulfamethoxazole. All of the isolates were susceptible to ceftaroline, daptomycin, linezolid, nitrofurantoin, quinupristin-dalfopristin, rifampin, tigecycline, and vancomycin. Of all the isolates, 82.6%, 67.8%, and 23.5% were susceptible to ciprofloxacin, erythromycin, and penicillin, respectively. No isolates harbored mupA or qacA/B genes, which suggested a lack of resistance to mupirocin or chlorhexidine. |
DOI | 10.1128/JCM.00270-16 |
Alternate Journal | J Clin Microbiol |
PubMed ID | 26962087 |
PubMed Central ID | PMC4844724 |
Related Faculty:
Lars Westblade, Ph.D.